110
Participants
Start Date
July 31, 2015
Primary Completion Date
September 30, 2015
Study Completion Date
October 31, 2015
4×10^10vp/1ml Ebola Zaire vaccine (Ad5-EBOV)
one dose, 4×10\^10vp/1ml per dose
1.6×10^11vp/2ml Ebola Zaire vaccine (Ad5-EBOV)
two doses, 0.8×10\^11vp/1ml per dose, with one dose to each arm at the same time
placebo
Phase 1 vaccine clinical trial center of Jiangsu Provincial Center for Disease Control and Prevention, Taizhou
Collaborators (1)
Beijing Institute of Biotechnology
OTHER
Tianjin Cansino Biotechnology Inc
INDUSTRY
Jiangsu Province Centers for Disease Control and Prevention
NETWORK